Skip to content

Faculty profile

Nick Daneman

Back to faculty
ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Signals and details

Research

Antimicrobial ResistanceBiomarkerC.Difficile InfectionChimeric Antigen Receptor T-Cell TherapyFeasibilityHematopoietic Stem Cell TransplantationMicrobiomePilot

Latest papers

  • Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

    CANADIAN MEDICAL ASSOCIATION JOURNAL · 2022

  • [Not Available].

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021 · senior author

  • The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021 · senior author

All 5 publications

Latest funding

  • Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial

    CIHR · 2025 · Principal investigator

    $100,000

  • A Cluster Randomized Cross-over Trial of an Antibiotic Decision Support Intervention in Sepsis (IDEAS II)

    CIHR · 2022 · Principal investigator

    $300,000

  • Incidence and risk factors of inappropriate antibiotic prescribing and related adverse health outcomes among Ontario long-term care residents and marginalized older community-dwelling adults with COVID-19 (I-CARE)

    CIHR · 2021 · Principal investigator

    $308,904
All 3 grants and awards
Something wrong or missing on this profile? Suggest a correction